- CSR Summary Not Available
- NCT03267576
- Primary Citation Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameCanagliflozinProduct NameINVOKANA®Therapeutic AreaCardiovascular and Metabolic DiseasesEnrollment64% Female44.4%% White0.0%
Product ClassSodium-Glucose Co-Transporter 2 (SGLT2) InhibitorSponsor Protocol Number28431754DIA4026Data PartnerJohnson & JohnsonCondition StudiedDiabetes Mellitus, Type 2Mean/Median Age (Years)45.3
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available